Clinical implications of antitelomeric drugs with respect to the nontelomeric functions of telomerase in cancer

References

• HuffmanKELeveneSDTesmerVMShayJWWrightWETelomere shortening is proportional to the size of the G-rich telomeric 3′-overhangJ Biol Chem200027526197191972210787419
   PubMed Web of Science ®Google Scholar
• HarleyCBFutcherABGreiderCWTelomeres shorten during ageing of human fibroblastsNature199034562744584602342578
   PubMed Web of Science ®Google Scholar
• GreiderCWBlackburnEHThe telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificityCell19875168878983319189
   PubMed Web of Science ®Google Scholar
• KimNWPiatyszekMAProwseKRSpecific association of human telomerase activity with immortal cells and cancerScience19942665193201120157605428
   PubMed Web of Science ®Google Scholar
• HemannMTGreiderCWWild-derived inbred mouse strains have short telomeresNucleic Acids Res200028224474447811071935
   PubMed Web of Science ®Google Scholar
• BlascoMATelomerase beyond telomeresNat Rev Cancer20022862763312154355
   PubMed Web of Science ®Google Scholar
• KangHJChoiYSHongSBEctopic expression of the catalytic subunit of telomerase protects against brain injury resulting from ischemia and NMDA-induced neurotoxicityJ Neurosci20042461280128714960598
   PubMed Web of Science ®Google Scholar
• RahmanRLatonenLWimanKGhTERT antagonizes p53-induced apoptosis independently of telomerase activityOncogene20052481320132715608686
   PubMed Web of Science ®Google Scholar
• SarinKYCheungPGilisonDConditional telomerase induction causes proliferation of hair follicle stem cellsNature200543670531048105216107853
   PubMed Web of Science ®Google Scholar
• LeeJSungYHCheongCTERT promotes cellular and organismal survival independently of telomerase activityOncogene200827263754376018223679
   PubMed Web of Science ®Google Scholar
• ChoiJSouthworthLKSarinKYTERT promotes epithelial proliferation through transcriptional control of aMyc- and Wnt-related developmental programPLoS Genet200841e1018208333
   PubMed Web of Science ®Google Scholar
• CongYShayJWActions of human telomerase beyond telomeresCell Res200818772573218574498
   PubMed Web of Science ®Google Scholar
• MartínezPBlascoMATelomeric and extra-telomeric roles for telomerase and the telomere-binding proteinsNat Rev Cancer201111316117621346783
   PubMed Web of Science ®Google Scholar
• YiXWhiteDMAisnerDLBaurJAWrightWEShayJWAn alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activityNeoplasia20002543344011191110
   PubMed Web of Science ®Google Scholar
• Saeboe-LarssenSFossbergEGaudemackGCharacterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT):analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissuesBMC Mol Biol200672616939641
   PubMed Web of Science ®Google Scholar
• WongMSChenLFosterCKainthlaRShayJWWrightWERegulation of telomerase alternative splicing: a target for chemotherapyCell Rep2013341028103523562158
   PubMed Web of Science ®Google Scholar
• DengYChanSSChangSTelomere dysfunction and tumour suppression: the senescence connectionNat Rev Cancer20088645015818500246
   PubMed Web of Science ®Google Scholar
• SperkaTWangJRudolphKLDNA damage checkpoints in stem cells, ageing and cancerNat Rev Mol Cell Biol201213957959022914294
   PubMed Web of Science ®Google Scholar
• YaarMEllerMSPanovaITelomeric DNA induces apoptosis and senescence of human breast carcinoma cellsBreast Cancer Res200791R1317257427
   PubMed Web of Science ®Google Scholar
• PuriNEllerMSByersHRDykstraSKuberaJGilchrestBATelomere-based DNA damage responses: a new approach to melanomaFASEBJ2004181213731381
   Web of Science ®Google Scholar
• EllerMSPuriNHadshiewIMVennaSSGilchrestBAInduction of apoptosis by telomere 3′ overhang-specific DNAExp Cell Res2002276218519312027448
   PubMed Web of Science ®Google Scholar
• EllerMSLiGZFiroozabadiRPuriNGilchrestBAInduction of a p95/Nbs1-mediated S phase checkpoint by telomere 3′ overhang specific DNAFASEB J20031721520162
   Web of Science ®Google Scholar
• EllerMSMaedaTMagnoniCAtwalDGilchrestBAEnhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS responseProc Natl Acad Sei U S A199794231262712632
   Web of Science ®Google Scholar
• GoukassianDABagheriSel-KeebLEllerMSGilchrestBADNA oligonucleotide treatment corrects the age-associated decline in DNA repair capacityFASEB J200216775475611923222
   PubMed Web of Science ®Google Scholar
• LongeHORomesserPBRankinAMTelomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potentialInt J Cancer2009124247348219003960
   PubMed Web of Science ®Google Scholar
• SarkarSFallerDVT-oligos inhibit growth and induce apoptosis in human ovarian cancer cellsOligonucleotides2011211475321281128
   PubMedGoogle Scholar
• PalaciosJAHerranzDDe BonisMLVelascoSSerranoMBlascoMASIRT1 contributes to telomere maintenance and augments global homologous recombinationJ Cell Biol201019171299131321187328
   PubMed Web of Science ®Google Scholar
• BryanTMEnglezouAGuptaJBacchettiSReddelRRTelomere elongation in immortal human cells without detectable telomerase activityEMBOJ1995141742404248
   PubMed Web of Science ®Google Scholar
• BryanTMEnglezouADalla-PozzaLDunhamMAReddelRREvidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell linesNat Med1997311127112749359704
   PubMed Web of Science ®Google Scholar
• ZahlerAMWilliamsonJRCechTRPrescottDMInhibition of telomerase by G-quartet DNA structuresNature199135063207187202023635
   PubMed Web of Science ®Google Scholar
• WangQLiuJQChenZG-quadruplex formation at the 3′ end of telomere DNA inhibits its extension by telomerase, polymerase and unwinding by helicaseNucleic Acids Res201139146229623721441540
   PubMed Web of Science ®Google Scholar
• ReadMHarrisonRJRomagnoliBStructure-based design of selective and potent G quadruplex-mediated telomerase inhibitorsProc Natl Acad Sei U S A200198948444849
   PubMed Web of Science ®Google Scholar
• InclesCMSchultesCMKempskiHKoehlerHKellandLRNeidleSA G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cellsMo! Cancer Ther200431012011206
   PubMed Web of Science ®Google Scholar
• GowanSMHarrisonJRPattersonLA G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activityMol Pharmacol20026151154116211961134
   PubMed Web of Science ®Google Scholar
• VasiliouVVasiliouKNebertDWHuman ATP-binding cassette (ABC) transporter familyHum Genomics20093328129019403462
   PubMedGoogle Scholar
• BlascoMALeeHWHandeMPTelomere shortening and tumor formation by mouse cells lacking telomerase RNACell199791125349335332
   PubMed Web of Science ®Google Scholar
• WangYTaoZZChenSMXiaoBKZhouXHLiuJPApplication of combination of short hairpin RNA segments for silencing VEGF, TERT and Bcl-xl expression in laryngeal squamous carcinomaCancer Biol Ther20087689690118367874
   PubMed Web of Science ®Google Scholar
• LiSCrothersJHaqqCMBlackburnEHCellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNAJ Biol Chem200528025237092371715831499
   PubMed Web of Science ®Google Scholar
• HerbertBSGeliertGCHochreiterALipid modification of GRN163, an N3′ – >P5′ thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibitionOncogene200524335262526815940257
   PubMed Web of Science ®Google Scholar
• GryaznovSPongraczKMatrayTTelomerase inhibitors – oligonucleotide pho sphoramidates as potential therapeutic agentsNucleosides Nucleotides Nucleic Acids20012040740141011563055
   PubMed Web of Science ®Google Scholar
• AsaiAOshimaYYamamotoYA novel telomerase template antagonist (GRN163) as a potential anticancer agentCancer Res200363143931393912873987
   PubMed Web of Science ®Google Scholar
• HerbertBSPongraczKShayJWGryaznovSMShea-HerbertBOligonucleotide N3′ – >P5′ phosphoramidates as efficient telomerase inhibitorsOncogene200221463864211850790
   PubMed Web of Science ®Google Scholar
• MarianCOChoSKMcEllinBMThe telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growthClin Cancer Res201016115416320048334
   PubMed Web of Science ®Google Scholar
• HashizumeROzawaTGryaznovSMNew therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163Neuro-oncology200810211212018287341
   PubMed Web of Science ®Google Scholar
• JosephITresslerRBassettEThe telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell linesCancer Res201070229494950421062983
   PubMed Web of Science ®Google Scholar
• SerranoDBleauAMFernandez-GarciaIInhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancerMol Cancer2011109621827695
   PubMed Web of Science ®Google Scholar
• PascoloEWenzCLingnerJMechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidateJ Biol Chem200227718155661557211854300
   PubMed Web of Science ®Google Scholar
• MuellerSHartmannUMayerFTargeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumorsInvest New Drugs200725651952417534576
   PubMed Web of Science ®Google Scholar
• CounterCMAvilionAALeFeuvreCETelomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activityEMBO J1992115192119291582420
   PubMed Web of Science ®Google Scholar
• GuoCGeverdDLiaoRHamadNCounterCMPriceDTInhibition of telomerase is related to the life span and tumorigenicity of human prostate cancer cellsJ Urol2001166269469811458119
   PubMed Web of Science ®Google Scholar
• ZhangRWangXGuoLXieHGrowth inhibition of BEL-7404 human hepatoma cells by expression of mutant telomerase reverse transcriptaseInt J Cancer200297217317911774261
   PubMed Web of Science ®Google Scholar
• MisawaMTauchiTSashidaGInhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cellsInt J Oncol20022151087109212370759
   PubMed Web of Science ®Google Scholar
• NguyenBNElmoreLWHoltSEMechanism of dominant-negative telomerase functionCell Cycle20098193227323319738429
   PubMed Web of Science ®Google Scholar
• KimJHParkSMKangMRUbiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERTGenes Dev200519777678115805468
   PubMed Web of Science ®Google Scholar
• LeeJHKhadkaPBaekSHChungIKCHIP promotes human telomerase reverse transcriptase degradation and negatively regulates telomerase activityJ Biol Chem201028553420334204520959453
   PubMed Web of Science ®Google Scholar
• OhWLeeEWLeeDHdm2 negatively regulates telomerase activity by functioning as an E3 ligase of hTERTOncogene201029284101411220453884
   PubMed Web of Science ®Google Scholar
• LiuJPChenWSchwarerAPLiHTelomerase in cancer immunotherapyBiochim Biophys Acta20101805135219751801
   PubMed Web of Science ®Google Scholar
• VonderheideRHHahnWCSchultzeJLNadlerLMThe telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytesImmunity199910667367910403642
   PubMed Web of Science ®Google Scholar
• DomchekSMRecioAMickRTelomerase-specific T-cell immunity in breast cancer:effect of vaccination on tumor immunosurveillanceCancer Res20076721105461055517974999
   PubMed Web of Science ®Google Scholar
• HernandezJGarcia-PonsFLoneYCIdentification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cellsProc Natl Acad Sei U S A200299191227512280
   Web of Science ®Google Scholar
• VetsikaEKKonsolakisGAggourakiDImmunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001Cancer Immunol Immunother201261215716821858533
   PubMed Web of Science ®Google Scholar
• ScardinoAGrossDAAlvesPHER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapyJ Immunol2002168115900590612023395
   PubMed Web of Science ®Google Scholar
• VonderheideRHDomchekSMSchultzeJLVaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytesClin Cancer Res200410382883914871958
   PubMed Web of Science ®Google Scholar
• ChenDYVanceBAThompsonLBDomchekSMVonderheideRHDifferential lysis of tumors by polyclonal T cell lines and T cell clones specific for hTERTCancer Biol Ther20076121991199618087213
   PubMed Web of Science ®Google Scholar
• BernhardtSLGjertsenMKTrachselSTelomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II studyBr J Cancer200695111474148217060934
   PubMed Web of Science ®Google Scholar
• KyteJACancer vaccination with telomerase peptide GV1001Expert Opin Investig Drugs2009185687694
   PubMed Web of Science ®Google Scholar
• BrunsvigPFAamdalSGjertsenMKTelomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancerCancer Immunol Immunother200655121553156416491401
   PubMed Web of Science ®Google Scholar
• NairSKHeiserABoczkowskiDInduction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cellsNat Med2000691011101710973321
   PubMed Web of Science ®Google Scholar
• SuZDannullJYangBKTelomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancerJ Immunol200517463798380715749921
   PubMed Web of Science ®Google Scholar
• SuZViewegJWeizerAZEnhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene productCancer Res200262175041504812208759
   PubMed Web of Science ®Google Scholar
• HoilsteinMSidranskyDVogelsteinBHarrisCCp53 mutations in human cancersScience1991253501549531905840
   PubMed Web of Science ®Google Scholar
• GreenblattMSBennettWPHollsteinMHarrisCCMutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesisCancer Res1994541848558788069852
   PubMed Web of Science ®Google Scholar
• AkeshimaRKigawaJTakahashiMTelomerase activity and p53-dependent apoptosis in ovarian cancer cellsBr J Cancer200184111551155511384107
   PubMed Web of Science ®Google Scholar
• DattaABellonMSinha-DattaUPersistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescenceBlood200610831021102916569765
   PubMed Web of Science ®Google Scholar
• BrassatUBalabanovSBaliDFunctional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cellsExp Hematol20113916676 e120940029
   PubMed Web of Science ®Google Scholar
• DingZWuCJJaskelioffMTelomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastasesCell2012148589690722341455
   PubMed Web of Science ®Google Scholar
• HahnWCStewartSABrooksMWInhibition of telomerase limits the growth of human cancer cellsNat Med19995101164117010502820
   PubMed Web of Science ®Google Scholar
• ZhangXMarVZhouWHarringtonLRobinsonMOTelomere shortening and apoptosis in telomerase-inhibited human tumor cellsGenes Dev199913182388239910500096
   PubMed Web of Science ®Google Scholar
• HarrisonRJCuestaJChessariGTri substituted acridine derivatives as potent and selective telomerase inhibitorsJ Med Chem200346214463447614521409
   PubMed Web of Science ®Google Scholar
• LeonettiCAmodeiSD’AngeloCBiological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alterationMol Pharmacol20046651138114615304549
   PubMed Web of Science ®Google Scholar
• Shin-yaKWierzbaKMatsuoKTelomestatin, a novel telomerase inhibitor from Streptomyces anulatusJ Am Chem Soc200112361262126311456694
   PubMed Web of Science ®Google Scholar